Persista Bio CEO to present at Meeting on the Mesa
IPITA Conference to include a presentation by Dr. Minglin Ma
Dr. Minglin Ma is a co-author on a newly published review of diabetes cell therapies
https://pubmed.ncbi.nlm.nih.gov/39227741 This review article describes current, developing and future cell replacement therapy options, touching on animal models and the regulatory environment.